
The study investigated the administration of antenatal corticosteroids (ACS) and its timing based on indications and maternal-obstetrical factors. The cohort was divided into two groups: those with optimally timed ACS administration (within 24 hours to 7 days) and those with suboptimally timed ACS administration (over 7 days). Optimal ACS timing was associated with nulliparity and preterm premature rupture of membranes, while suboptimal timing was associated with chronic hypertension and asymptomatic cervical shortening. Optimal ACS timing was linked to a higher rate of neonatal intensive care unit admission. The study suggests that the timing of ACS administration should be adjusted based on individual maternal characteristics and indications to maximize its benefits.
Like
Save
Share